vs
LXP Industrial Trust（LXP）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
LXP Industrial Trust的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$86.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -14.0%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 0.3%）
LXP工业信托是一家公开上市的房地产投资信托，专注于持有、运营和投资美国核心市场的优质工业地产，主要涵盖配送中心、物流设施及轻型工业物业，服务电商、第三方物流、先进制造等领域租户，为投资者创造长期稳定收益。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LXP vs PBYI — 直观对比
营收规模更大
LXP
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出41.7%
-14.0%
两年增速更快
PBYI
近两年复合增速
0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.7M | $75.5M |
| 净利润 | $28.8M | — |
| 毛利率 | 81.5% | 69.3% |
| 营业利润率 | 34.6% | 22.7% |
| 净利率 | 33.2% | — |
| 营收同比 | -14.0% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LXPPBYI
| Q4 25 | $86.7M | $75.5M | ||
| Q3 25 | $86.9M | $54.5M | ||
| Q2 25 | $87.7M | $52.4M | ||
| Q1 25 | $88.9M | $46.0M | ||
| Q4 24 | $100.9M | $59.1M | ||
| Q3 24 | $85.6M | $80.5M | ||
| Q2 24 | $85.8M | $47.1M | ||
| Q1 24 | $86.3M | $43.8M |
净利润LXPPBYI
| Q4 25 | $28.8M | — | ||
| Q3 25 | $36.3M | $8.8M | ||
| Q2 25 | $29.1M | $5.9M | ||
| Q1 25 | $19.0M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.3M | $20.3M | ||
| Q2 24 | $5.4M | $-4.5M | ||
| Q1 24 | $-269.0K | $-4.8M |
毛利率LXPPBYI
| Q4 25 | 81.5% | 69.3% | ||
| Q3 25 | 82.3% | 77.7% | ||
| Q2 25 | 81.9% | 76.5% | ||
| Q1 25 | 80.7% | 77.1% | ||
| Q4 24 | 85.3% | 76.4% | ||
| Q3 24 | 82.5% | 63.9% | ||
| Q2 24 | 82.0% | 77.4% | ||
| Q1 24 | 82.4% | 75.5% |
营业利润率LXPPBYI
| Q4 25 | 34.6% | 22.7% | ||
| Q3 25 | 50.4% | 17.6% | ||
| Q2 25 | 33.7% | 12.7% | ||
| Q1 25 | 21.8% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | 7.9% | 27.4% | ||
| Q2 24 | 6.9% | -4.6% | ||
| Q1 24 | 1.0% | -5.3% |
净利率LXPPBYI
| Q4 25 | 33.2% | — | ||
| Q3 25 | 41.7% | 16.2% | ||
| Q2 25 | 33.2% | 11.2% | ||
| Q1 25 | 21.4% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.4% | 25.2% | ||
| Q2 24 | 6.3% | -9.6% | ||
| Q1 24 | -0.3% | -11.0% |
每股收益（稀释后）LXPPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.12 | $0.17 | ||
| Q2 25 | $0.09 | $0.12 | ||
| Q1 25 | $0.06 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $0.02 | $0.41 | ||
| Q2 24 | $0.01 | $-0.09 | ||
| Q1 24 | $-0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $170.4M | $97.5M |
| 总债务越低越好 | $1.4B | $22.7M |
| 股东权益账面价值 | $2.0B | $130.3M |
| 总资产 | $3.5B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.66× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LXPPBYI
| Q4 25 | $170.4M | $97.5M | ||
| Q3 25 | $229.7M | $94.4M | ||
| Q2 25 | $71.0M | $96.0M | ||
| Q1 25 | $70.9M | $93.2M | ||
| Q4 24 | $101.8M | $101.0M | ||
| Q3 24 | $55.0M | $96.7M | ||
| Q2 24 | $48.7M | $96.8M | ||
| Q1 24 | $293.8M | $107.2M |
总债务LXPPBYI
| Q4 25 | $1.4B | $22.7M | ||
| Q3 25 | $1.5B | $34.0M | ||
| Q2 25 | $1.5B | $45.3M | ||
| Q1 25 | $1.5B | $56.7M | ||
| Q4 24 | $1.6B | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益LXPPBYI
| Q4 25 | $2.0B | $130.3M | ||
| Q3 25 | $2.1B | $115.3M | ||
| Q2 25 | $2.1B | $104.7M | ||
| Q1 25 | $2.1B | $97.1M | ||
| Q4 24 | $2.1B | $92.1M | ||
| Q3 24 | $2.1B | $71.1M | ||
| Q2 24 | $2.1B | $48.5M | ||
| Q1 24 | $2.2B | $51.0M |
总资产LXPPBYI
| Q4 25 | $3.5B | $216.3M | ||
| Q3 25 | $3.7B | $202.9M | ||
| Q2 25 | $3.7B | $194.9M | ||
| Q1 25 | $3.8B | $196.2M | ||
| Q4 24 | $3.8B | $213.3M | ||
| Q3 24 | $3.9B | $220.7M | ||
| Q2 24 | $3.9B | $205.0M | ||
| Q1 24 | $4.2B | $214.1M |
负债/权益比LXPPBYI
| Q4 25 | 0.66× | 0.17× | ||
| Q3 25 | 0.72× | 0.30× | ||
| Q2 25 | 0.72× | 0.43× | ||
| Q1 25 | 0.73× | 0.58× | ||
| Q4 24 | 0.75× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $188.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 6.56× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流LXPPBYI
| Q4 25 | $188.7M | $14.4M | ||
| Q3 25 | $63.5M | $9.7M | ||
| Q2 25 | $44.3M | $14.1M | ||
| Q1 25 | $39.0M | $3.6M | ||
| Q4 24 | $211.2M | $15.6M | ||
| Q3 24 | $64.6M | $11.0M | ||
| Q2 24 | $38.5M | $1.0M | ||
| Q1 24 | $38.9M | $11.2M |
自由现金流LXPPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率LXPPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度LXPPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率LXPPBYI
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | 1.10× | ||
| Q2 25 | 1.52× | 2.41× | ||
| Q1 25 | 2.05× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | 0.54× | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
